IBDEI07F ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3313,1,5,0)
 ;;=5^Neuropathic Pain
 ;;^UTILITY(U,$J,358.3,3313,2)
 ;;=Neuropathic Pain^82605
 ;;^UTILITY(U,$J,358.3,3314,0)
 ;;=053.19^^33^276^32
 ;;^UTILITY(U,$J,358.3,3314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3314,1,4,0)
 ;;=4^053.19
 ;;^UTILITY(U,$J,358.3,3314,1,5,0)
 ;;=5^Post-Herpetic Neuralgia
 ;;^UTILITY(U,$J,358.3,3314,2)
 ;;=^266544
 ;;^UTILITY(U,$J,358.3,3315,0)
 ;;=310.9^^33^276^26
 ;;^UTILITY(U,$J,358.3,3315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3315,1,4,0)
 ;;=4^310.9
 ;;^UTILITY(U,$J,358.3,3315,1,5,0)
 ;;=5^Organic Brain Syndrome
 ;;^UTILITY(U,$J,358.3,3315,2)
 ;;=^123952
 ;;^UTILITY(U,$J,358.3,3316,0)
 ;;=332.0^^33^276^28
 ;;^UTILITY(U,$J,358.3,3316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3316,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,3316,1,5,0)
 ;;=5^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,3316,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,3317,0)
 ;;=250.60^^33^276^29
 ;;^UTILITY(U,$J,358.3,3317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3317,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,3317,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,3317,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,3318,0)
 ;;=356.9^^33^276^31
 ;;^UTILITY(U,$J,358.3,3318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3318,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,3318,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,3318,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,3319,0)
 ;;=780.2^^33^276^39
 ;;^UTILITY(U,$J,358.3,3319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3319,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,3319,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,3319,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,3320,0)
 ;;=724.3^^33^276^35
 ;;^UTILITY(U,$J,358.3,3320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3320,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,3320,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,3320,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,3321,0)
 ;;=780.39^^33^276^37
 ;;^UTILITY(U,$J,358.3,3321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3321,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,3321,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,3321,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,3322,0)
 ;;=782.0^^33^276^27
 ;;^UTILITY(U,$J,358.3,3322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3322,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,3322,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,3322,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,3323,0)
 ;;=435.9^^33^276^41
 ;;^UTILITY(U,$J,358.3,3323,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3323,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,3323,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,3323,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,3324,0)
 ;;=354.2^^33^276^43
 ;;^UTILITY(U,$J,358.3,3324,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3324,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,3324,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,3324,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,3325,0)
 ;;=729.1^^33^276^18
 ;;^UTILITY(U,$J,358.3,3325,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3325,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,3325,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,3325,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,3326,0)
 ;;=438.20^^33^276^6
 ;;^UTILITY(U,$J,358.3,3326,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3326,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,3326,1,5,0)
 ;;=5^CVA w/Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,3326,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,3327,0)
 ;;=438.12^^33^276^5
 ;;^UTILITY(U,$J,358.3,3327,1,0)
 ;;=^358.31IA^5^2
